Patents by Inventor Stephen Yan Tat Chan

Stephen Yan Tat Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarker SPAG5
    Patent number: 10775381
    Abstract: There has been a recent shift in cancer therapy from one size fits all to a personalized and tailored treatment for individual patients to increase efficiency and avoid unnecessary toxicity. This invention relates to a method of determining the prognosis and suitable treatment of cancer in a subject by measuring the level of expression of SPAG5. In particular, it relates to a method where high expression of SPAG5 in tumour cells correlates with aggressive tumours.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: September 15, 2020
    Assignees: NOTTINGHAM TRENT UNIVERSITY, NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST
    Inventors: Graham Roy Ball, Stephen Yan Tat Chan, Tarek Mohamed Ahmed Abdel-Fatah
  • Breast cancer assay
    Patent number: 9791448
    Abstract: The application describes a method of screening for breast cancer by testing fro the amount of HAGE (Helicase antigen) in a sample of breast tissue. Methods of prognosis of samples of breast cancer tumours are also provided. HAGE+ ER? (estrogen receptor-) cancers are indicated as being amenable to chemotherapy. Methods of treating breast cancers with HAGE-specific CTA antigen or HAGE-specific antibodies are also provided.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: October 17, 2017
    Assignee: THE NOTTINGHAM TRENT UNIVERSITY
    Inventors: Adam Linley, Stephanie Mcardle, Chungui Lu, Robert Rees, Stephen Yan Tat Chan, Tarek Mohamed Ahmed Abdel-Fateh